Cargando…

PT666. Check an effeciency About the Suvorexant with Combining Other Sleep Promoting Medicines

Detalles Bibliográficos
Autores principales:	Akira Iwanami, Toshiaka Tsuneoka, Matsuzaki, Sayaka, Ohta, Haruhisa, Saga, Nobuyuki, Sasamori, Hiroki, Yamada, Hiroki, Yokoyama, Sachiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616998/ http://dx.doi.org/10.1093/ijnp/pyw044.666

Ejemplares similares

Dose Consolidation Can Be an Effecient Intervention
por: Baldinger, Sandra
Publicado: (2004)

PS38. Psychotropic medication for bipolar patients in the psychiatric acute inpatient unit.
por: Sasamori, Hiroki, et al.
Publicado: (2016)

PT653. Experience using suvorexant to treat delirium
por: Fujiwara, Kodo, et al.
Publicado: (2016)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Clinical Characteristics of Women with ADHD in Japan
por: Hayashi, Wakaho, et al.
Publicado: (2019)

JLab experiment E93050 virtual Compton scattering scientillators effeciency
por: Bertin, P Y, et al.
Publicado: (2000)

PM354. The effects of visual cues on for the ultimatum game in persons with autism spectrum disorders
por: Ikuse, Daisuke, et al.
Publicado: (2016)

PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Large‐Scale Asymmetric Synthesis of Fmoc‐(S)‐2‐Amino‐6,6,6‐Trifluorohexanoic Acid
por: Yin, Zizhen, et al.
Publicado: (2019)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

Run 666, R1 + R2
por: Accomazzo, C, et al.
Publicado: (1976)

Commande R/637'666/PS/APA
por: Jacob, U
Publicado: (1980)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
por: Toi, Norikazu, et al.
Publicado: (2018)

Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial
por: Azuma, Kazunari, et al.
Publicado: (2018)

666. Evaluation of Vancomycin Harms for Intra-abdominal Infections
por: McCoy, Christopher, et al.
Publicado: (2023)

Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021)

Atypical alert state control in adult patients with ADHD: A pupillometry study
por: Shirama, Aya, et al.
Publicado: (2020)

An effective and effecient peptide binding prediction approach for a broad set of HLA-DR molecules based on ordered weighted averaging of binding pocket profiles
por: Shen, Wen-Jun, et al.
Publicado: (2013)

Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
por: McGaughey, Georgia, et al.
Publicado: (2014)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Alterations of local spontaneous brain activity and connectivity in adults with high-functioning autism spectrum disorder
por: Itahashi, Takashi, et al.
Publicado: (2015)

Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study
por: Uemura, Sachiko Ito, et al.
Publicado: (2022)

Steroid Metabolism in Thermophilic Actinobacterium Saccharopolyspora hirsuta VKM Ac-666(T)
por: Lobastova, Tatyana, et al.
Publicado: (2021)

FRI666 Postbariatric Hypoglycemia: The Brody School Of Medicine Institutional Experience
por: Jiang, Zhaozhi, et al.
Publicado: (2023)

Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
por: Tamura, Kiyoshi, et al.
Publicado: (2018)

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium
por: Nazeer, Sahana, et al.
Publicado: (2023)

Quantification of Suvorexant in Human Urine Using a Validated HPTLC Bioanalytical Method
por: Alqarni, Mohammed H., et al.
Publicado: (2023)

Functional Alterations in Neural Substrates of Geometric Reasoning in Adults with High-Functioning Autism
por: Yamada, Takashi, et al.
Publicado: (2012)

Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions
por: Bredrup, Cecilie, et al.
Publicado: (2021)

Mortality in 787,666 school pupils with and without autism: A cohort study
por: Smith, Gillian S, et al.
Publicado: (2020)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j7pdks3v4rc26ug3o5v48ottq5